It’s hard to ignore the ripple effects of U.S. Treasury yields and the ever-growing national debt. As someone who tracks the markets daily, I’ve come to realize that these two forces play a more critical role than most casual investors … Continue Reading
When I first saw the headline – OpenAI acquires Jony Ive’s startup in a $6.5 billion deal – my initial thought wasn’t about OpenAI. It was about Apple. And as expected, by midday Apple’s shares had slipped close to 2%, … Continue Reading
The U.S. stock market finally hit the pause button on May 20, 2025, after a six-day winning streak that had investors cheering. The S&P 500 slipped 0.4%, the Dow dipped 0.3%, and the Nasdaq fell 0.4% – nothing dramatic, but … Continue Reading
Home Depot is set to release its Q1 2025 earnings on May 20, 2025, and expectations are running high. While revenue growth appears solid, thanks to strategic moves like the SRS Distribution acquisition, investors should brace for some earnings pressure. … Continue Reading
Biotech Buzz: Why Regeneron Is Trending Now Regeneron Pharmaceuticals (NASDAQ: REGN) has been making headlines – and not without reason. On May 19, 2025, the biotech giant announced it had won the bankruptcy auction for most of 23andMe’s assets, sealing … Continue Reading
The U.S. stock market started the new week on uncertain footing, digesting fresh headlines about a credit rating downgrade from Moody’s. Yet despite early jitters, the major indices ended Monday in the green, signaling surprising resilience from investors. Let’s break … Continue Reading